Principal investigator for COVID-19 vaccine interviewed by The Ledger - Alcanza Clinical Research

Create a Profile

I accept digital forms of communication(Required)
This field is hidden when viewing the form
This field is hidden when viewing the form
This field is for validation purposes and should be left unchanged.

Create a Profile

I accept digital forms of communication(Required)
This field is hidden when viewing the form
This field is hidden when viewing the form
This field is for validation purposes and should be left unchanged.

Get In Touch Mobile

I accept digital forms of communication(Required)
This field is for validation purposes and should be left unchanged.

FIND A TRIAL NEAR YOU

No location found for this Zip Code

-- or --

No location found for this Location

FIND A TRIAL NEAR YOU

No location found for this Zip Code

-- or --

No location found for this Location
Back
Date Published: 12/03/2020

Principal investigator for COVID-19 vaccine interviewed by The Ledger

Dr. James Andersen, a principal investigator for Accel Research Sites’ COVID-19 vaccine trials, was recently interviewed.

The interview was conducted by The Ledger in Lakeland on the new trials beginning in December.

Andersen speaks to who they are looking for in terms of participants and what we can expect to see next.

See the full article here.

Back

Articles

Ready to be part of healthcare history? Find the right clinical trial for you.

Get In Touch

I accept digital forms of communication(Required)
This field is for validation purposes and should be left unchanged.
Accessibility Adjustment

Color Adjustment

Orientation Adjustment

Font Size

 

Line height